Abstract
Newly released guidelines from the Infectious Diseases Society of America (IDSA) use a question-and- answer approach to help clinicians choose the best treatments for patients infected with methicillin-resistant Staphylococcus aureus (MRSA). The guidelines include recommendations for the treatment of hospital- and community-associated MRSA infections in children and adults. Common infections of the skin and soft tissues are addressed along with rarer but more serious problems such as blood infections, endocarditis, pneumonia, and bone and joint infections. Pharmacists who specialize in infectious diseases say the guidelines contain nothing surprising, but they praise the document as a concise source of current information on how to deal with MRSA in a variety of settings. “I think anyone who sees patients with infections should read them,” said Jason Gallagher, infectious diseases pharmacist in the department of pharmacy practice at Temple University in Philadelphia. Gallagher said MRSA-related admissions are a daily occurrence at his medical center and constitute “a very large percentage of people” who require an infectious diseases consultation.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
